SynthesisCancer2026

Outcomes of loncastuximab tesirine in heavily pretreated patients with diffuse large B-cell lymphoma, including the post-CAR T-cell therapy setting: A meta-analysis.

Fernando Gibran-Nunes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.